Immunosenescence and the risk of disease modifying therapies in Multiple Sclerosis

被引：0
|
作者：
Mehling, M.
机构：
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
基金：
瑞士国家科学基金会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
FW16-3
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [1] Assessing the risk of multiple sclerosis disease-modifying therapies
    Ayrignac, Xavier
    Bilodeau, Philippe-Antoine
    Prat, Alexandre
    Girard, Marc
    Labauge, Pierre
    Le Lorier, Jacques
    Larochelle, Catherine
    Duquette, Pierre
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (07) : 695 - 706
  • [2] Disease modifying therapies in multiple sclerosis
    Sharrack, B.
    Jenkins, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 532 - 534
  • [3] Disease modifying therapies in multiple sclerosis
    Khatri, BO
    McQuillen, MP
    NEUROLOGY, 2002, 59 (03) : 471 - 472
  • [4] Risk of depression in multiple sclerosis across disease-modifying therapies
    Longinetti, Elisa
    Frisell, Thomas
    Englund, Simon
    Reutfors, Johan
    Fang, Fang
    Piehl, Fredrik
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (04) : 632 - 641
  • [5] Disease modifying therapies in multiple sclerosis - Reply
    Goodin, DS
    NEUROLOGY, 2002, 59 (03) : 472 - 473
  • [6] RANKING OF DISEASE -MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS
    Fogarty, E.
    Schmitz, S.
    Walsh, C.
    Barry, M.
    VALUE IN HEALTH, 2015, 18 (07) : A750 - A750
  • [7] Disease modifying therapies for relapsing multiple sclerosis
    Wingerchuk, Dean M.
    Weinshenker, Brian G.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [8] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [9] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [10] Disease-modifying therapies for multiple sclerosis
    John R. Corboy
    Douglas S. Goodin
    Elliot M. Frohman
    Current Treatment Options in Neurology, 2003, 5 (1) : 35 - 54
12345